185,400
-1.54%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Park Systems
Its shares trade on KOSDAQ under the ticker 140860.KQ. It has been listed since 17 December 2015. In the fiscal year to 31 December 2025, it reported revenue of ₩205.61bn and net income of ₩34.48bn. At that date it held total assets of ₩349.92bn and shareholders' equity of ₩225.12bn.
Park Systems Corp. engages in the development and manufacture of atomic force microscopy products. The company is headquartered in Suwon, Gyeonggi-Do. The company went IPO on 2015-12-17. The firm's product portfolio consists of research equipments including Park NX10, Park NX20, Park XE7, Park XE15 and others; industrial AFMs including Park NX-Hivac, Park HDM series, Park PTR series, Park Wafer series, Park 3DM series and others; bio AFMS including Park NX-Bio, Park NX10 scanning ion conductance microscopes (SICMs) and others and research and industrial accessories. The firm distributes its products within domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Information Technology
- Industry
- Electronic Equipment, Instruments & Components
- Listed since
- 17 Dec 2015
- Website
- parksystems.com ↗
Leadership
Pay as last reported
- Mr. Sang Yil ParkChief Executive Officer, Director
- Ms. Yeon Ok ChoManaging Director
- Mr. Yeong Guk YooManaging Director
- Mr. Byeong Wun AhnAssistant Managing Director
- Mr. Sang Jun ChoAssistant Managing Director
- Mr. Eun Hyeok ChoiAssistant Managing Director
- Mr. Hui Chun KangAssistant Managing Director
- Mr. Chang Yik LeeInternal Auditor
- Mr. Dong Chun LeeAssistant Managing Director
- Mr. Do Gyu WooAssistant Managing Director
- Mr. Seung Gi ChaeNon-Executive Independent Director
- Mr. Gi Yeong ChoiNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Park NX10 atomic force microscopy product leads in research equipment segment.
- Park NX-Hivac industrial AFM series excels in vacuum applications globally.
- Park NX-Bio bio AFM product serves specialized medical research markets.
Weaknesses
- Park XE7 research equipment lacks advanced features compared to competitors.
- Park XE15 industrial AFM series faces limited market penetration in Europe.
- Park 3DM series accessories have high production costs for small businesses.
Opportunities
- Expanding Park HDM series into emerging markets like India and Brazil.
- Increasing demand for Park PTR series in semiconductor manufacturing sectors.
- Growing market for Park Wafer series in electronics fabrication industries.
Threats
- Competition from Park NX20 in the research equipment market segment.
- Regulatory changes affecting Park XE15 industrial AFM applications.
- Supply chain disruptions impacting Park 3DM series accessory production.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.